These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19672574)

  • 1. Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice.
    Lebrun P; Cognard E; Bellon-Paul R; Gontard P; Filloux C; Jehl-Pietri C; Grimaldi P; Samson M; Pénicaud L; Ruberte J; Ferre T; Pujol A; Bosch F; Van Obberghen E
    Diabetologia; 2009 Oct; 52(10):2201-12. PubMed ID: 19672574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.
    Rieusset J; Bouzakri K; Chevillotte E; Ricard N; Jacquet D; Bastard JP; Laville M; Vidal H
    Diabetes; 2004 Sep; 53(9):2232-41. PubMed ID: 15331532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3).
    Yang Z; Hulver M; McMillan RP; Cai L; Kershaw EE; Yu L; Xue B; Shi H
    PLoS One; 2012; 7(10):e47493. PubMed ID: 23115649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells.
    Liu X; Mameza MG; Lee YS; Eseonu CI; Yu CR; Kang Derwent JJ; Egwuagu CE
    Diabetes; 2008 Jun; 57(6):1651-8. PubMed ID: 18356406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells.
    Eguchi M; Gillis LC; Liu Y; Lyakhovsky N; Du M; McDermott JC; Sweeney G
    Mol Cell Endocrinol; 2007 Mar; 267(1-2):38-45. PubMed ID: 17223256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity.
    Galic S; Sachithanandan N; Kay TW; Steinberg GR
    Biochem J; 2014 Jul; 461(2):177-88. PubMed ID: 24966052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression.
    Spangenburg EE; Brown DA; Johnson MS; Moore RL
    J Physiol; 2006 May; 572(Pt 3):839-48. PubMed ID: 16484300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.
    Mashili F; Chibalin AV; Krook A; Zierath JR
    Diabetes; 2013 Feb; 62(2):457-65. PubMed ID: 23043161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-fat feeding increases insulin receptor and IRS-1 coimmunoprecipitation with SOCS-3, IKKalpha/beta phosphorylation and decreases PI-3 kinase activity in muscle.
    Yaspelkis BB; Kvasha IA; Figueroa TY
    Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1709-15. PubMed ID: 19386987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion.
    Lebrun P; Cognard E; Gontard P; Bellon-Paul R; Filloux C; Berthault MF; Magnan C; Ruberte J; Luppo M; Pujol A; Pachera N; Herchuelz A; Bosch F; Van Obberghen E
    Diabetologia; 2010 Sep; 53(9):1935-46. PubMed ID: 20499047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of pancreatic beta-cell mass and proliferation by SOCS-3.
    Lindberg K; Rønn SG; Tornehave D; Richter H; Hansen JA; Rømer J; Jackerott M; Billestrup N
    J Mol Endocrinol; 2005 Oct; 35(2):231-43. PubMed ID: 16216905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
    Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
    J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of down-regulation of suppressor of cellular signaling proteins by RNAi on glucose transport of intrauterine growth retardation rats.
    Liao L; Zheng R; Wang C; Gao J; Ying Y; Ning Q; Luo X
    Pediatr Res; 2011 Jun; 69(6):497-503. PubMed ID: 21364493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection.
    Rønn SG; Börjesson A; Bruun C; Heding PE; Frobøse H; Mandrup-Poulsen T; Karlsen AE; Rasschaert J; Sandler S; Billestrup N
    Diabetologia; 2008 Oct; 51(10):1873-82. PubMed ID: 18648765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley P
    Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*.
    Sadowski CL; Choi TS; Le M; Wheeler TT; Wang LH; Sadowski HB
    J Biol Chem; 2001 Jun; 276(23):20703-10. PubMed ID: 11279166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
    Ling C; Billig H
    Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells.
    Bruun C; Heding PE; Rønn SG; Frobøse H; Rhodes CJ; Mandrup-Poulsen T; Billestrup N
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):32-8. PubMed ID: 19643162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity.
    Jorgensen SB; O'Neill HM; Sylow L; Honeyman J; Hewitt KA; Palanivel R; Fullerton MD; Öberg L; Balendran A; Galic S; van der Poel C; Trounce IA; Lynch GS; Schertzer JD; Steinberg GR
    Diabetes; 2013 Jan; 62(1):56-64. PubMed ID: 22961088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS proteins causing trouble in insulin action.
    Lebrun P; Van Obberghen E
    Acta Physiol (Oxf); 2008 Jan; 192(1):29-36. PubMed ID: 18171427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.